herenciageneticayenfermedad: Respiratory Diseases - Nov 5, 2018 Edition :: Medical News

lunes, 5 de noviembre de 2018

Respiratory Diseases - Nov 5, 2018 Edition :: Medical News | Medical Articles

	November 5, 2018
	Respiratory Diseases
	The latest respiratory diseases news from News Medical

Novel method uses just a drop of blood to monitor effect of lung cancer therapy

Dr Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of which was nivolumab (Opdivo).

			Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

			Patients with severe asthma may benefit from newly developed targeted treatments In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways.

	Air pollution on the rise outside GP offices and hospitals finds study A new report has shown that the air outside the offices of General Practitioners and outside hospitals are high in pollutants. This can aggravate the lung problems in patients of asthma and Chronic Obstructive Pulmonary Disease (COPD) says the report.

	Eating fish as part of diet can reduce asthma symptoms in children, shows trial A clinical trial led by La Trobe University has shown eating fish such as salmon, trout and sardines as part of a healthy diet can reduce asthma symptoms in children. The international study found children with asthma who followed a healthy Mediterranean diet enriched with fatty fish had improved lung function after six months.

	Lung cancer mortality rates are 28% lower in California Early adoption of tobacco control efforts in California lead to fewer people ever smoking, reduced the amount used by those who do smoke and helped smokers quit at a younger age -- when their risk of developing lung cancer is lowest.

	Aggressive local therapy for stage IV lung cancer patients improves progression-free survival Adding radiation therapy or surgery to systemic therapy for stage IV lung cancer patients whose cancer has spread to a limited number of sites can extend overall survival time significantly, according to new results from a multicenter, randomized, controlled phase II study. The findings were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology